Task: Answer the multiple-choice question.
Question: Which drug exhibits a 5.906% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
(a) C/C(=N\NC(=O)Cc1cccn1C)c1ccc2ccccc2c1
(b) O=C(CSc1n[nH]c(=O)n1-c1ccccc1)Nc1ccccc1
Answer: b. O=C(CSc1n[nH]c(=O)n1-c1ccccc1)Nc1ccccc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C(CSc1n[nH]c(=O)n1-c1ccccc1)Nc1ccccc1
O=C(CSc1n[nH]c(=O)n1-c1ccccc1)Nc1ccccc1
2-[(5-oxo-4-phenyl-1H-1,2,4-triazol-3-yl)sulfanyl]-N-phenylacetamide